Plain-English translation of NCT07446777 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Multiple Myeloma research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is testing whether a combination of prolonged overnight fasting (going without food for extended periods at night) and a Mediterranean-style diet—rich in vegetables, beans, nuts, and healthy oils—can be feasible and helpful for people with multiple myeloma or precursor conditions. Researchers want to see if this dietary approach is realistic for patients to follow while undergoing myeloma treatment, and whether it might support their overall health and disease management.
Doctors are looking for additional lifestyle tools that might complement standard myeloma therapy and improve outcomes for patients. This study explores whether dietary changes—specifically fasting and Mediterranean eating patterns—could be a practical and beneficial addition to care.
You likely qualify if…
You likely don't qualify if…
If you join the active treatment group, you'll follow prolonged overnight fasting and a Mediterranean diet for about 6 to 8 months, supported by dietary workbooks, a nutrition journal, and a Fitbit device to track your progress. You'll receive regular coaching and guidance to help you stick with the plan. If you're assigned to the waitlist control group, you'll continue with your normal routine for the study period, and then receive one educational session about the benefits of fasting and Mediterranean eating at the end.
AI-generated summary from trial data · Jun 10, 2026 · Not medical advice
United States